1-6 of 6
Daniel I Nathan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis

Dahniel L Sastow, Daniel I. Nathan, Hannah Levavi, Jonathan Feld, Douglas Tremblay
Journal: Blood
Blood (2024) 144 (Supplement 1): 5182.
https://doi.org/10.1182/blood-2024-197986
Published: 2024
Journal Articles

TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

Shivani Handa, Yosef Joseph Rene Amel Riazat-Kesh, Richard J Butterfield, Ganesh Sivakumar, Sangeetha Venugopal, Erin McGovern, Jonathan Feld, Douglas Tremblay, Sebastian Elghaity-Beckley, Marina Kremyanskaya, John O. Mascarenhas, Blake Langlais, Gina L. Mazza, Daniel I. Nathan, Joseph Tripodi, Vesna Najfeld, Amylou C Dueck, Raajit Rampal, Ronald Hoffman, Bridget Kelly Marcellino
Journal: Blood
Blood (2024) 144 (Supplement 1): 243.
https://doi.org/10.1182/blood-2024-206688
Published: 2024
Journal Articles

The Presence of Ring Chromosomes in Patients with Myeloid Neoplasms Is Predictive of a Poor Outcome

Daniel I. Nathan, Ronald Hoffman, Daiva Ahire, John Mascarenhas, Lewis R. Silverman, Vesna Najfeld, Jonathan Feld
Journal: Blood
Blood (2023) 142 (Supplement 1): 2940.
https://doi.org/10.1182/blood-2023-179585
Published: 2023
Journal Articles

Characterization of Myeloid Neoplasms in Inflammatory Bowel Disease

Daniel I Nathan, David Mueller, Angela Liu, John Mascarenhas, Bridget K Marcellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 4056–4057.
https://doi.org/10.1182/blood-2022-160476
Published: 2022
Journal Articles

Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

Bridget K Marcellino, Cara Clementelli, Kristin Beaumont, Christoph Schaniel, Min Lu, Karie Chen, Adena Russel, Ayman Mohammad, Daniel I Nathan, Jake Aronin, Alan H. Shih, Robert Sebra, Ronald Hoffman
Journal: Blood
Blood (2022) 140 (Supplement 1): 797–798.
https://doi.org/10.1182/blood-2022-170232
Published: 2022
Journal Articles

Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy

Daniel I. Nathan, MD, Douglas Tremblay, MD, Santiago Thibaud, MD, John Mascarenhas, MD, Janice L. Gabrilove, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
https://doi.org/10.1182/blood-2020-137005
Published: 2020